Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
PERTUZUMAB-TRASTUZUMAB-HYALURONIDASE 60-60-2000 MG-MG-U/ML SOLN SOLUTION (NDC 50242-260-01) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 19, 2026 , from http://ppman.hank.ai/transparency/procedure/50242-260-01/by-state?code_type=NDC
“PERTUZUMAB-TRASTUZUMAB-HYALURONIDASE 60-60-2000 MG-MG-U/ML SOLN SOLUTION (NDC 50242-260-01) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/50242-260-01/by-state?code_type=NDC. Accessed
November 19, 2026 .
“PERTUZUMAB-TRASTUZUMAB-HYALURONIDASE 60-60-2000 MG-MG-U/ML SOLN SOLUTION (NDC 50242-260-01) by State,” HANK Price Transparency ,
accessed November 19, 2026 ,
http://ppman.hank.ai/transparency/procedure/50242-260-01/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
50242-260-01 — Pertuzumab-trastuzumab-hyaluronidase 60-60-2000 Mg-mg-u/ml Soln Solution
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$151
National median
$123 – $184
IQR (p25 – p75)
2
hospitals filing
2
states
Walking in without insurance?
Cash / self-pay price
Cash median
$595
vs. negotiated
+294.3%
Hospitals reporting
15
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 50242-260-01 (NDC), with interquartile range
State Median p25 p75
MD $16,942 $16,942 $16,942
IL $147 $120 $176